Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193805-21-000214
Filing Date
2021-02-12
Accepted
2021-02-12 12:40:25
Documents
1
Group Members
DEERFIELD MANAGEMENT COMPANY, L.P.DEERFIELD MGMT III, L.P.DEERFIELD MGMT, L.P.DEERFIELD PARTNERS, L.P.DEERFIELD PRIVATE DESIGN FUND II, L.P.DEERFIELD PRIVATE DESIGN FUND III, L.P.DEERFIELD PRIVATE DESIGN INTERNATIONAL II, L.P.

Document Format Files

Seq Description Document Type Size
1 e620287_sc13ga-alimera.htm SC 13G/A 155422
  Complete submission text file 0001193805-21-000214.txt   157002
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Subject) CIK: 0001267602 (see all company filings)

EIN.: 200028718 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-85452 | Film No.: 21624861
SIC: 2834 Pharmaceutical Preparations

Mailing Address 780 THIRD AVENUE 37TH FLOOR NEW YORK NY 10017
Business Address
Flynn James E (Filed by) CIK: 0001352546 (see all company filings)

Type: SC 13G/A